7th Annual Peptides & Oligonucleotides Congress

by BiopharmaTrend        Undefined

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

   1031    Comments 0

With major developments in the peptide field and with more and more peptide and oligonucleotide therapeutics entering clinical trials, the real promise of peptides and oligonucleotides is starting to be realised. Part of our Biologics Series, this event will take you through the key stages of peptide development from peptide discovery through to formulation and delivery, manufacturing and synthesis, as well as oligonucleotide synthesis, chemistry, formulation, as well as therapeutics and manufacturing.

Over 150 attendees working in peptides and oligonucleotides, representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions.

Over 40 case studies, presentations and panel discussions focused on the key issues in peptide technologies, therapeutics case studies, discovery & development of oligonucleotide therapeutics, manufacturing and process development.

View Agenda: http://bit.ly/35u2EnA


27 April 2019 – Day One (Kick-off Session)

  • Turning Challenges to Successes in Peptides Delivery & Formulation

28 April 2020 – Day Two

  • Peptide Design, Synthesis, Purification & Analytical Technologies
  • Peptide Manufacturing & Process Development
  • Oligonucleotide Synthesis, Chemistry, Formulation & Delivery, Process & Analytical Development

29 April 2020 – Day Three

  • Peptide Therapeutics: Case Studies, Immunogenicity & Novel Disease Treatments
  • Oligonucleotide Therapeutics & Manufacturing

Date: 27 - 29 April 2020

Location: London, UK

Share this:              


There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *